In March 2025, the company introduced new options for the immediate-to-purchaser presenting of its Wegovy weight loss drug. The company set up a new pharmacy, known as NovoCare, which would charge customers $499 per month for usage of the drug, less than fifty percent the cost of the drug by other pharmaceutical distribution networks.[fifty three]U